[COVID-19] Delhi High Court asks Centre, Delhi govt to ensure transparent, efficient, timely allocation of Tocilizumab

Roche India informed the Court that in view of the COVID-19 situation in India, it has decided on its own to immediately supply 10,000 doses of Tocilizumab 400 MG, free of cost.
Delhi High Court
Delhi High Court
Published on
2 min read

The Delhi High Court has asked the Central government and the Delhi government to take immediate steps to ensure that COVID-19 drug Tocilizumab is allocated in a transparent and timely manner for the benefit of patients in need (Dharmendra Kumar v. GNCTD).

Loading content, please wait...
Bar and Bench - Indian Legal news
www.barandbench.com